Strong Cresemba (isavuconazole) sales performance in Asia Pacific and China triggers further milestone payment to Basilea | The Manila Times

Allschwil, Switzerland, June 05, 2025
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today tha
Read more...